Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma

Author(s):
Piperno-Neumann, S.; Kapiteijn, E.; Larkin, J.M.G.; Carvajal, R.D.; Luke, J.J.; Seifert, H.; Roozen, I.; Zoubir, M.; Yang, L.; Choudhury, S.; Yerramilli-Rao, P.; Hodi, F.S.; Schwartz, G.K.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-05-20
Language
English
Is part of
Journal of Clinical Oncology (2014), No. 15
hdl
1887/105164